Biotech companies can skyrocket in a short period because of excellent clinical or regulatory progress. And if we take the ...

In the most recent quarter, Realty Income generated $1.05 per share in adjusted funds from operations (AFFO), which are the ...

It has been a rough few months to be invested in homebuilder stocks. This is especially true for Sun Belt-focused builder ...

We recently published a list of 10 Worst Beaten Down Stocks to Buy Now. In this article, we are going to take a look at where ...

With hundreds of billions in net sales in 2024, coupled with the fact that nearly 40% of all spending online in the U.S. happens on its website, Amazon is likely a top choice among investors who are ...

Goeasy ( TSX:GSY) is a popular stock among investors looking for growth opportunities in the financial sector. But with its stock recently dipping below $170, many are wondering whether it’s time to ...

US stock futures steady as traders await PPI data and monitor tariffs. Cisco surges on AI growth while markets eye Fed policy ...

The Philadelphia Eagles are NFL champs, so it's time to party. Here's what we know about the upcoming parade and how to get ...

Though it has now been a commercial-stage company ... that could deliver monster returns to shareholders down the road. Before you buy stock in CRISPR Therapeutics, consider this: The Motley ...

JB Hi-Fi delivered a broad beat across key metrics, including revenue, net profit, and dividends, with strong January sales growth across Australia, New Zealand, and The Good Guys.

Nearly a year ago, Viking Therapeutics (NASDAQ: VKTX) shares exploded higher after the clinical-stage drugmaker announced successful results from a clinical trial with an experimental weight loss ...